Navigation Links
Immunosyn Corporation Files 10-Q
Date:5/16/2008

abetic ulcers. Immunosyn went public in January 2007 and its stock began trading on October 26, 2007 on the OTCBB under the symbol "IMYN."

About Immunosyn Corporation

La Jolla, CA-headquartered Immunosyn Corporation (OTC Bulletin Board: IMYN) plans to market and distribute life enhancing therapeutics. Currently, the company has exclusive worldwide rights from its largest shareholder, Argyll Biotechnologies, LLC, to market, sell and distribute SF-1019, a compound that was developed from extensive research into Biological Response Modifiers (BRMs). Argyll Biotechnologies, LLC has initiated the process for regulatory approval of SF-1019 in several countries and preparations for clinical trials are underway in both the US and Europe. Research suggests that SF-1019 has the potential to affect a number of clinical conditions including complications from Diabetic Mellitus such as Diabetic Neuropathy (DN) and diabetic ulcers (DU), auto-immune disorders such as Multiple Sclerosis (MS) and neurological disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Reflex Sympathetic Dystrophy Syndrome (RSD or RSDS).

The above news release contains forward-looking statements. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and are subject to a wide range of business risks, external factors and uncertainties. Actual results may differ materially from those indicated by such forward-looking statements. For additional information, please consult the Company's most recent public filings and Annual Report on Form 10-K for its most recent fiscal year. The Company assumes no obligation to update the information contained in this press release, whe
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Immunosyn Corporation Announces 2007 Results, Files 10KSB
2. USANAs CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporations Board of Directors
3. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
4. WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
5. Immunosyn Corporation Names G. David Criner as CFO
6. Immunosyn Corporation to Present at FSX
7. CorVel Corporation Announces Earnings Release Webcast
8. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
9. Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards
10. Pharmos Corporation to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Triple-S Management Corporation Appoints New Non-Executive Chairman to Board; Adds New Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... September 23, 2014 Proove Biosciences ... will be presenting research on the association between specific ... U.S. Psychiatric and Mental Health Congress’ 27th ... conference focuses on the theme of ‘Embracing Change.’ Mental ... a changing landscape. From the challenges presented by the ...
(Date:9/23/2014)... Manassas, VA (PRWEB) September 23, 2014 ... organization, is pleased to announce two important appointments to ... as Executive Vice President of Strategy and Technology and ... Director for the Standards Resource Center. Both roles are ... Raymond H. Cypess, President and CEO at ATCC described ...
(Date:9/23/2014)... and ANNAPOLIS JUNCTION, MD (PRWEB) September 23, 2014 ... research leader in personalized medicine, presented industry leading research ... misuse this past weekend at the American Academy ... The meeting took place in Phoenix, Arizona at the ... study on the linkage between gender and genetic predisposition ...
(Date:9/23/2014)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced three ... to $5 million. The orders are all odour control projects ... continue to see new orders coming in," said Peter ... has climbed to over $11 million." About ... company that designs, manufactures and distributes a comprehensive line of ...
Breaking Biology Technology:Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 2Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 3
... FluForecast(R) warning in April 7th, 2008, a year before ... was able to state the likelihood of H1N1 outbreaks ... examines specific regions in virus genes which have been ... as published on the Web, stated that in H1N1 ...
... Cellectricon, a leading,provider of automated screening solutions ... BioFocus DPI, a contract research organization with,leading ... will utilize,Cellectricon,s Dynaflow(R)HT, a fully automated patch ... screening capacity, particularly,for fast ligand-gated ion channels. ...
... Microparticles AB, the Swedish,life science technology company, ... production based on supercritical fluid technology.,The Company,s ... drawbacks of traditional micronization and is well ... all the advantages of earlier supercritical,fluid technologies ...
Cached Biology Technology:Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 'Swine Flu' Virus Outbreak 2Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 'Swine Flu' Virus Outbreak 3Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug Discovery 2Xspray Expands to Meet Pharma's Interest in its Ground-Breaking Particle Production Technology 2Xspray Expands to Meet Pharma's Interest in its Ground-Breaking Particle Production Technology 3
(Date:9/22/2014)... (Sept. 22, 2014) As genetic sequencing technologies continue ... is a critical need to establish appropriate policies and ... experts have said. A special policy issue of the ... online today and edited by experts with the Center ... of Medicine gives policy makers the tools to jumpstart ...
(Date:9/22/2014)... Ill. Antarctic fishes that manufacture their own ... Ocean also suffer an unfortunate side effect, researchers ... their bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences ... an undesirable consequence of the evolution of antifreeze ...
(Date:9/22/2014)... the fires captured in this image burn in Khabarovsk Krai, ... Dozens of red hotspots, accompanied by plumes of smoke mark ... blows to the east towards the Sea of Okhotsk. ... this area, swampy forest inhabit the central depression, and deciduous ... large wildfires are common in Russia in the summer, the ...
Breaking Biology News(10 mins):Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3
... Medicine have developed a new animal model for studying hemophilia ... disorder. Hemophilia A, a hereditary defect that prevents blood from ... the factor VIII gene. Published online in the Journal ... better understanding of hemophilia A, according to first author and ...
... of the H5N1 ,bird flu, virus in South East Asia ... of wild birds could lead to global pandemic. Such fears ... Ecological Society,s Journal of Applied Ecology reveals why ... wildfowl is unlikely but also provides a new framework for ...
... Sept. 2, 2010 The American Society for Biochemistry ... week in response to the Aug. 23 ruling in ... that granted a preliminary injunction barring federal funding of ... said the decision, which came in response to a ...
Cached Biology News:Yale develops new animal model for hemophilia A 2Satellite data reveal why migrating birds have a small window to spread bird flu 2American Society for Biochemistry and Molecular Biology reacts to stem-cell ruling 2
... Tray (3 per pack), 1. ... blot processing.Automated staining of Coomassie Blue ... nucleic acid analysis.Prepares blots for high ... control of protocol, solution, volume, and ...
... 1 g. High quality kits ... preparation that give consistent and ... and tissues.Clean up samples from ... Accurately quantitate protein for first-dimension ...
GOAT ANTI CARICA PAPAYA PAPAIN...
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
Biology Products: